Biological Effects of Monoenergetic Carbon Ions and Their Associated Secondary Particles

DNA double-strand breaks (DSBs) are the main factor behind carbon-ion radiation therapy (CIRT)-induced cell death. Nuclear interactions along the beam path between the primary carbon ions and targets result in nuclear fragmentation of carbon ions and recoiled particles. These secondary particles tra...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 788293
Main Authors Buglewicz, Dylan J, Walsh, Kade D, Hirakawa, Hirokazu, Kitamura, Hisashi, Fujimori, Akira, Kato, Takamitsu A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 17.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:DNA double-strand breaks (DSBs) are the main factor behind carbon-ion radiation therapy (CIRT)-induced cell death. Nuclear interactions along the beam path between the primary carbon ions and targets result in nuclear fragmentation of carbon ions and recoiled particles. These secondary particles travel further distances past the Bragg peak to the tail region, leading to unwanted biological effects that may result in cytotoxicity in critical organs and secondary induced tumors following CIRT. Here, we confirmed that the density of the DSB distributions increases as the cell survival decreases at the Bragg peak and demonstrated that by visualizing DSBs, the various LET fragmentation ions and recoiled particles produced differences in their biological effects in the post-Bragg peak tail regions. This suggests that the density of the DSBs within the high-LET track structures, rather than only their presence, is important for inducing cell death. These results are essential for CIRT treatment planning to limit the amount of healthy cell damage and reducing both the late effect and the secondary tumor-associated risk.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology
Edited by: Pankaj Chaudhary, Queen’s University Belfast, United Kingdom
Reviewed by: Laure Sabatier, Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), France; Mark A. Hill, University of Oxford, United Kingdom; Elettra Valentina Bellinzona, University of Trento, Italy
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.788293